Quantcast
Last updated on April 19, 2014 at 7:46 EDT

Latest Roche Group Stories

2013-11-05 12:28:52

TUCSON, Ariz., Nov. 5, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with Incyte Corporation to collaborate on the development of companion diagnostic tests for Incyte's oncology drug programs, beginning with the Incyte IDO1 inhibitor program. As part of the agreement, Ventana will support Incyte's personalized medicine healthcare strategies for cancer drug development using its vast...

2013-11-04 08:27:18

PALMS study finds dual-biomarker test to be highly sensitive and specific for cervical precancers TUCSON, Ariz., Nov. 4, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, is pleased to announce the positive findings of the Primary ASC-US LSIL Marker Study (PALMS) that have been published in The Journal of the National Cancer Institute.(1) The pan-European study, including more than 27,000 women from five European countries, was performed to...

2013-10-22 12:28:21

TUCSON, Ariz., Oct. 22, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the VENTANA Gram Staining Kit(1). Automated for use on the VENTANA BenchMark Special Stains instrument, the Gram Staining Kit aids pathologists in the most basic classification of bacteria into Gram-positive and Gram-negative bacteria in fixed tissue samples. Gram stain classification is clinically useful as it provides an initial...

2013-10-01 12:31:10

Exclusive license agreement paves the way for industry's first BRAF V600E IHC test TUCSON, Ariz., Oct 1, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the industry's first BRAF V600E immunohistochemistry (IHC) test(1) to detect the BRAF V600E mutation in a variety of tumors. The test is designed to detect the most frequent BRAF mutation, V600E, which has been found to play a key role in a variety of...

2013-10-01 12:30:40

Leading scientists join together to discuss breakthrough research that addresses serious medical needs BASEL, Switzerland and NEW YORK, Oct. 1, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alexandria Real Estate Equities, Inc. (NYSE: ARE) inaugurated today the Translational and Clinical Research Center (TCRC) at the prestigious Alexandria Center for Life Science in Manhattan's East Side Medical Corridor by hosting New York officials and dignitaries as well as life...

2013-09-19 08:27:44

TUCSON, Ariz. and INGELHEIM, Germany, Sept. 19, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, and Boehringer Ingelheim (BI) announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs. (Photo: http://photos.prnewswire.com/prnh/20130919/LA82369) As part of the agreement, Ventana will utilize its immunohistochemistry technology platform,...

2013-09-11 12:24:27

VENTANA ALK (D5F3) IHC assay will aid in the identification of patients for Pfizer's XALKORI in China TUCSON, Ariz., Sept. 11, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the approval of the VENTANA ALK immunohistochemistry (IHC) assay by the Chinese Food and Drug Administration (CFDA) as a companion diagnostic to aid in the identification of patients for Pfizer's CFDA-approved oncology product XALKORI® (crizotinib). The...

2013-09-10 04:22:10

BASEL, Switzerland and BLUE BELL, Pa., Sept. 10, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B. The licensed compounds are currently in preclinical development and have generated robust T-cell responses...

2013-07-30 12:28:52

Advanced system helps medical labs improve efficiency and speed of blood sample testing HOUSTON, July 30, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses and maximize patient safety. "This total lab automation solution can...

2013-07-18 16:26:18

Technology Offers a Solution TUCSON, Ariz., July 18, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced a groundbreaking study in the Journal of Histotechnology that indicates there is a real risk that errors can be made in the processing of patient biopsy tissue in anatomic pathology labs around the world. The Journal reports on the startling outcome of the Stainer Bath Cross Contamination Challenge (SBCCC), developed by Ventana...